138 related articles for article (PubMed ID: 31862523)
1. DNMT3A overexpression is associated with aggressive behavior and enteroblastic differentiation of gastric adenocarcinoma.
Kataoka I; Funata S; Nagahama K; Isogaya K; Takeuchi H; Abe N; Shibahara J
Ann Diagn Pathol; 2020 Feb; 44():151456. PubMed ID: 31862523
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
Murakami T; Yao T; Mitomi H; Morimoto T; Ueyama H; Matsumoto K; Saito T; Osada T; Nagahara A; Watanabe S
Gastric Cancer; 2016 Apr; 19(2):498-507. PubMed ID: 25893262
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics of gastric adenocarcinoma with enteroblastic differentiation and gastric adenocarcinoma with enteroblastic marker expression.
Abe D; Akazawa Y; Yatagai N; Hayashi T; Ueyama H; Mine S; Fukunaga T; Nagahara A; Yao T; Saito T
Virchows Arch; 2023 Sep; 483(3):405-414. PubMed ID: 37581693
[TBL] [Abstract][Full Text] [Related]
4. Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological study of five cases.
Murakami T; Yao T; Yatagai N; Yamashiro Y; Saito T; Sakamoto N; Nagahara A
Histopathology; 2020 Jan; 76(2):325-332. PubMed ID: 31429980
[TBL] [Abstract][Full Text] [Related]
5. Molecular and clinicopathological features of colorectal adenocarcinoma with enteroblastic differentiation.
Yamashiro Y; Saito T; Hayashi T; Murakami T; Yanai Y; Tsuyama S; Suehara Y; Takamochi K; Yao T
Histopathology; 2020 Sep; 77(3):492-502. PubMed ID: 32438490
[TBL] [Abstract][Full Text] [Related]
6. Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma.
Akazawa Y; Saito T; Hayashi T; Yanai Y; Tsuyama S; Akaike K; Suehara Y; Takahashi F; Takamochi K; Ueyama H; Murakami T; Watanabe S; Nagahara A; Yao T
Hum Pathol; 2018 Aug; 78():79-88. PubMed ID: 29751042
[TBL] [Abstract][Full Text] [Related]
7. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
8. Clinicopathological features of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation.
Matsumoto K; Ueyama H; Matsumoto K; Akazawa Y; Komori H; Takeda T; Murakami T; Asaoka D; Hojo M; Tomita N; Nagahara A; Kajiyama Y; Yao T; Watanabe S
World J Gastroenterol; 2016 Sep; 22(36):8203-10. PubMed ID: 27688662
[TBL] [Abstract][Full Text] [Related]
9. [Gastric adenocarcinoma with enteroblastic differentiation and elevated serum alpha fetoprotein].
Li QZ; Zhao HB; Ban N; Wang Q; Zhang JJ; Ding SN; Li HH; Zhou ZH
Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):886-890. PubMed ID: 32892552
[No Abstract] [Full Text] [Related]
10. Integrated clinicopathological and immunohistochemical analysis of gastric adenocarcinoma with hepatoid differentiation: an exploration of histogenesis, molecular characteristics, and prognostic markers.
He F; Fu Y; Sun Q; Geng P; Zheng Z; Pu X; Shi J; Fan X
Hum Pathol; 2021 Sep; 115():37-46. PubMed ID: 33636206
[TBL] [Abstract][Full Text] [Related]
11. Frequent loss of heterozygosity of SMAD4 locus and prognostic impacts of SMAD4 immunohistochemistry in gastric adenocarcinoma with enteroblastic differentiation.
Yatagai N; Saito T; Akazawa Y; Hayashi T; Yanai Y; Tsuyama S; Murakami T; Ueyama H; Watanabe S; Nagahara A; Yao T
Hum Pathol; 2019 Jun; 88():18-26. PubMed ID: 30946932
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological features of rectal adenocarcinoma with enteroblastic differentiation].
Liu J; Liu XL; Lin DL; Zhao H; Li YJ; Xing XM
Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):797-801. PubMed ID: 37527983
[No Abstract] [Full Text] [Related]
13. Esophageal adenocarcinoma with enteroblastic differentiation arising in ectopic gastric mucosa in the cervical esophagus: a case report and literature review.
Gushima R; Narita R; Shono T; Naoe H; Yao T; Sasaki Y
J Gastrointestin Liver Dis; 2017 Jun; 26(2):193-197. PubMed ID: 28617891
[TBL] [Abstract][Full Text] [Related]
14. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.
Fujimoto M; Matsuzaki I; Nishino M; Iwahashi Y; Warigaya K; Kojima F; Ono K; Murata SI
J Clin Pathol; 2018 Jul; 71(7):600-607. PubMed ID: 29305518
[TBL] [Abstract][Full Text] [Related]
15. Ampullary Carcinosarcoma with Enteroblastic Differentiation: A Case Report.
Haider MA; Naqvi S; Barakat O; Wilken SE; Dhingra S
Ann Clin Lab Sci; 2021 Jan; 51(1):131-135. PubMed ID: 33653792
[TBL] [Abstract][Full Text] [Related]
16. Fetal gut-like differentiation in gallbladder cancer.
Koyama K; Maeda D; Tamura D; Narita C; Kudo-Asabe Y; Sato T; Yamamoto Y; Sageshima M; Nanjo H; Goto A
Hum Pathol; 2017 Dec; 70():27-34. PubMed ID: 28970139
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological features of gastric adenocarcinoma with enteroblastic differentiation: a report of twelve cases].
Li JZ; Huang HJ; Chen XY; Chen X
Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):626-631. PubMed ID: 34078051
[No Abstract] [Full Text] [Related]
18. Gastric adenocarcinoma with enteroblastic differentiation should be differentiated from hepatoid adenocarcinoma: A study with emphasis on clear cells and clinicopathologic spectrum.
Kwon MJ; Byeon S; Kang SY; Kim KM
Pathol Res Pract; 2019 Sep; 215(9):152525. PubMed ID: 31301878
[TBL] [Abstract][Full Text] [Related]
19. Gastric Cancer With Primitive Enterocyte Phenotype: An Aggressive Subgroup of Intestinal-type Adenocarcinoma.
Yamazawa S; Ushiku T; Shinozaki-Ushiku A; Hayashi A; Iwasaki A; Abe H; Tagashira A; Yamashita H; Seto Y; Aburatani H; Fukayama M
Am J Surg Pathol; 2017 Jul; 41(7):989-997. PubMed ID: 28505005
[TBL] [Abstract][Full Text] [Related]
20. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
Osada M; Aishima S; Hirahashi M; Takizawa N; Takahashi S; Nakamura K; Tanaka M; Maehara Y; Takayanagi R; Oda Y
Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]